Press releases
In accordance with the French Public Health Code, only information intended for the general public is available on this website. For communications relating to our medicinal products, please contact us at: communication@horus-pharma.fr
Plastic neutrality: Horus Pharma continues its commitment in 2026 alongside Plastic Bank
Since the partnership was launched in late 2022, this initiative has enabled the collection and recycling of just under 450 tonnes of plastic waste.
Horus Pharma announces strategic Agreement to commercialize Formycon’s Aflibercept Biosimilar
today announced that it has entered into a strategic collaboration with Klinge Biopharma GmbH and Formycon AG for the semi-exclusive commercialization of Formycon’s Eylea® biosimilar FYB203 (Aflibercept).
Horus Pharma takes another step forward in its international expansion
Already present in over 30 countries, Horus Pharma is accelerating its international expansion with distribution agreements covering eight new countries.
Horus Pharma continues its European expansion
Horus Pharma today announced its first investment in a foreign company with the acquisition of a significant stake in Inocare Pharm.